We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Thermo Fisher Scientific Inc | NYSE:TMO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 1.87 | 0.33% | 573.60 | 575.00 | 566.95 | 567.94 | 1,438,185 | 01:00:00 |
From Apr 2019 to Apr 2024
By Imani Moise
Thermo Fisher Scientific Inc. said its fourth-quarter earnings rose, led by strength in its life sciences segment.
The lab-equipment company has relied largely on acquisitions to grow, spending $5.5 billion on deals during the 2016 fiscal year.
In all for the quarter the company reported a profit of $629.5 million, or $1.59 a share, up from $602.6 million, or $1.50, a year earlier. Excluding items like acquisition-related costs, earnings rose to $2.41 per share from $2.12 in 2015.
Revenue grew 6.5% to $4.95 billion.
Analysts polled by Thomson Reuters had forecast earnings of $2.38 per share on $4.98 billion in revenue.
Shares closed at $143.29 after Monday trading and were inactive premarket. The stock has risen 8.5% over the past 12 months.
Write to Imani Moise at imani.moise@wsj.com
(END) Dow Jones Newswires
January 31, 2017 09:18 ET (14:18 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Thermo Fisher Scientific Chart |
1 Month Thermo Fisher Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
